It may be noted that Drug Controller General of India (DCGI) on Sunday approved two vaccines Covishield of Serum Institute of India and Covaxin of Bharat Biotech against the disease.
Later on the day, All India Institute Of Medical Science (AIIMS) Director Randeep Guleria said initially, Serum Institute vaccine will be given and the vaccine developed by Bharat Biotech will be used as a backup.
Also Read: Bharat Biotech’s Coavaxin Can Be Used As Backup, Says AIIMS Director Dr Randeep Guleria